Connecticut-based private equity firm Olympus Partners has acquired ONsite Mammography from Colorado-based private equity firm, Revelstoke Capital Partners.
In partnership with OB/GYN and primary care physicians, ONsite Mammography offers mammography, screening ultrasound and risk assessment services at over 75 locations across the U.S.
"The strategic and multisite healthcare expertise that Revelstoke brought to ONsite was helpful in our growth over the years as we have expanded to become the leading developer and operator of women's health imaging services," said Karl Schmidt, ONsite CEO. "We are excited to partner with Olympus to continue to build upon our success."
Since Revelstoke's investment in November 2017, ONsite has nearly tripled its footprint and annual exam volume.
"Annual mammography screening is well recognized as a vital contributor to improving breast cancer outcomes. ONsite's in-office mammography services improve compliance with annual screening guidelines in a more convenient and comfortable environment, all while offering care in a lower cost setting and reads by the highest quality breast imaging-focused radiologists," said Griffin Barstis, principal at Olympus, in a statement. "We are excited to partner with Karl Schmidt and the ONsite team to further expand the company's services across the country."
The spending bill signed by President Trump on Sunday will secure access to mammography screening
for women under the age of 50, extending the moratorium on 2009 and 2016 United States Preventive Services Task Force (USPSTF) Breast Cancer Screening Guidelines from December 31, 2021 to December 31, 2022. Without this added protection gained in the Consolidated Appropriations Act, 2021 (Omnibus and Coronavirus Relief Bill), under the Affordable Care Act (ACA), mammography coverage for women younger than 50 might have been impacted starting January 1, 2022.